Latin America Annual Meeting

Take advantage of opportunities for networking and knowledge sharing with key stakeholders influencing the advancement and implementation of initiatives in Latin America and the Caribbean.

Send Email 1.888.257.6457

ハイライト＆特長

What is happening at Latin America Annual Meeting

Gain exclusive insights into current and future trends in regulatory, clinical, and pharmacovigilance (PV) across Latin America
Hear directly from regional and global experts, including regulators, industry leaders, and key stakeholders shaping the future of drug development
Engage with high-impact sessions, plenary and concurrent tracks covering pressing topics in regulatory affairs, clinical operations, safety and PV
Access cross-functional discussions that highlight the interconnected nature of regulatory, clinical, and safety strategies
Explore region-specific challenges and opportunities, with solutions tailored for Latin America’s unique regulatory and public health environments
Expand your professional network with influential voices across industry, government, and academia
Take home actionable knowledge and best practices to strengthen compliance, streamline development, and improve healthcare outcomes
Participate in intimate, neutral forums that encourage collaboration and honest dialogue
Be part of the conversation shaping drug development policy and practice in Latin America and beyond

Track Alignment for 2026!

Regulatory/Clinical Track:

The regulatory/clinical track provides a dynamic platform to explore the evolving regulatory landscape and clinical research practices across Latin America. Participants will engage with case studies, best practices and emerging trends in life science R&D, with a special focus on integrating medical devices into regulatory and clinical frameworks. This track highlights innovative approaches to compliance, multi-regional cooperation, and practical strategies for the successful development and management of both pharmaceutical products and medical devices.

Safety and Pharmacovigilance Track: